Procyrion, Inc., a medical device firm developing the first catheter-deployed circulatory assist device intended for long-term use in the treatment of chronic heart failure, has been awarded a $50,000 grant from the National Capital Consortium for Pediatric Device Innovation. The award, part of the FDA Pediatric Device Consortia grant program, presented five innovators with up…